China Health Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	29.78	26.45	21.43	13.09	83.6	83.06
Revenue	29.78	26.45	21.43	13.09	83.6	83.06
Revenue Growth (YoY)	20.61%	23.47%	63.68%	-84.34%	0.65%	31.40%
Cost of Revenue	17.75	16.39	13.21	7.35	13.24	16.1
Gross Profit	12.03	10.07	8.21	5.74	70.36	66.96
Selling, General & Admin	10.48	10.08	7.61	13.97	21.39	11.89
Other Operating Expenses	-0.31	-0.31	-0	-0.05	-0	-0.07
Operating Expenses	24.97	24.57	65.54	21.75	28.27	11.82
Operating Income	-12.94	-14.51	-57.33	-16.01	42.09	55.14
Interest Expense	-	-	-	-0.02	-0.02	-0.16
Interest & Investment Income	0.08	0.06	0.12	0.2	0.43	0.23
Other Non Operating Income (Expenses)	-0.03	-0.03	-1	-	-	-
EBT Excluding Unusual Items	-12.89	-14.47	-58.21	-15.83	42.5	55.21
Gain (Loss) on Sale of Assets	-	-	-	-	0.02	15.59
Pretax Income	-12.89	-14.47	-58.21	-15.83	42.52	70.8
Income Tax Expense	0.28	0.05	-	-	6.2	10.15
Earnings From Continuing Operations	-13.17	-14.52	-58.21	-15.83	36.33	60.65
Minority Interest in Earnings	-	-	0.2	-	-	-
Net Income	-13.17	-14.52	-58.01	-15.83	36.33	60.65
Net Income to Common	-13.17	-14.52	-58.01	-15.83	36.33	60.65
Net Income Growth	-	-	-	-	-40.11%	118.23%
Shares Outstanding (Basic)	995	995	995	995	995	994
Shares Outstanding (Diluted)	995	995	995	995	995	997
Shares Change (YoY)	-	-	-	-	-0.18%	0.44%
EPS (Basic)	-0.01	-0.01	-0.06	-0.02	0.04	0.06
EPS (Diluted)	-0.01	-0.01	-0.06	-0.02	0.04	0.06
EPS Growth	-	-	-	-	-39.98%	117.19%
Free Cash Flow	15.18	8.52	-4.88	-5.16	-10.28	19.11
Free Cash Flow Per Share	0.01	0.01	-0.01	-0.01	-0.01	0.02
Gross Margin	40.39%	38.05%	38.33%	43.87%	84.16%	80.61%
Operating Margin	-43.46%	-54.84%	-267.57%	-122.31%	50.34%	66.38%
Profit Margin	-44.23%	-54.88%	-270.78%	-120.90%	43.45%	73.02%
Free Cash Flow Margin	50.97%	32.22%	-22.79%	-39.39%	-12.29%	23.01%
EBITDA	-12.15	-13.9	-57.09	-15.86	42.29	55.32
EBITDA Margin	-40.80%	-52.55%	-266.48%	-121.16%	50.58%	66.61%
D&A For EBITDA	0.79	0.61	0.23	0.15	0.2	0.18
EBIT	-12.94	-14.51	-57.33	-16.01	42.09	55.14
EBIT Margin	-43.46%	-54.84%	-267.57%	-122.31%	50.34%	66.38%
Effective Tax Rate	-	-	-	-	14.57%	14.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.